MedWatch

Amplifon doubles Q2 sales and upgrades 2021 guidance

In Q2, hearing aid seller Amplifon made significant progress on multiple markets, leading the Italian company to raise its guidance for all of 2021.

The covid-19 crisis seems to have loosened its grip on the hearing aid industry, which was heavily affected by the virus last year.

Italian hearing aid seller Amplifon, which is a client of both Demant and GN Hearing, has had the wind in its sails during Q2 this year.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs